IN BRIEF: Biotech Growth Trust underperforms against annual benchmark
1st Jun 2022 12:30
Biotech Growth Trust PLC - London-based investor in global biotechnology companies - Net asset value per share at March 31, end of financial year, falls 34% to 957.8 pence from 1,446.4p a year ago. Nasdaq Biotechnology Index, its benchmark, fell 7.4% during period. Biotech Growth underperformed benchmark. "Following the very strong results of the previous year, this has been a difficult year for the company," says Chair Andrew Joy. Read More